Screening for High Frequency Malignant Disease

The SHIELD (Screening for High Frequency Malignant Disease) study is a prospective, observational, multi-site basket design trial without randomization. The primary objective of the study is to evaluate the sensitivity and specificity of a blood-based GuardantLUNAR-2 test to detect high frequency cancer in screen-relevant populations.

For more information please visit https://clinicaltrials.gov/study/NCT05117840

Interested in Volunteering for the Study?

If you would like more information about this study, please call us at 318-212-8671 .